Research & Development Market Research Reports & Industry Analysis
New product design and development is essential for the survival and growth of many companies, as markets and consumers’ tastes are fickle and the competition can be fierce. In order to stay relevant in a fast changing marketplace, firms have to constantly revise and expand their range of product offerings. Therefore, research and development is of great economic importance as companies fight to maintain their market share, though it may mean forgoing current profits in favor of potential future performance and returns.
Research and development is most often associated with the technology industry, as well as with science and in particular with healthcare and the development of new pharmaceuticals, diagnostics or medical devices that are safe and effective. For instance, drug makers must constantly search for the next big blockbuster drug, since the products they currently have on the market will eventually lose their patent protection and be vulnerable to generic competition. So they spend huge amounts of money on R&D because without a promising drug pipeline their revenue stream will ultimately dry up.
Research & Development Industry Research & Market Reports
-
In Vivo Toxicology
... at a CAGR of 6.4% over the analysis period 2024-2030. In Vivo Toxicology Consumables, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$6.8 Billion by the ... Read More
-
Quantum Computing in Healthcare
... 2030, growing at a CAGR of 36.9% over the analysis period 2024-2030. Quantum Computing Services, one of the segments analyzed in the report, is expected to record a 40.1% CAGR and reach US$452.4 Million by ... Read More
-
Cancer Therapies
... CAGR of 10.4% over the analysis period 2024-2030. Chemotherapy, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$112.8 Billion by the end of the analysis period. ... Read More
-
Orphan Drugs
... CAGR of 12.0% over the analysis period 2024-2030. Biologic Drugs, one of the segments analyzed in the report, is expected to record a 12.8% CAGR and reach US$308.5 Billion by the end of the analysis ... Read More
-
Cannabis Testing
... CAGR of 13.1% over the analysis period 2024-2030. Cannabis Testing Services, one of the segments analyzed in the report, is expected to record a 14.9% CAGR and reach US$1.7 Billion by the end of the ... Read More
-
Legal Marijuana
... CAGR of 22.3% over the analysis period 2024-2030. Marijuana Oil & Tinctures, one of the segments analyzed in the report, is expected to record a 23.4% CAGR and reach US$89.4 Billion by the end of ... Read More
-
Life Science Analytics
... at a CAGR of 13.3% over the analysis period 2024-2030. Life Science Analytics Services, one of the segments analyzed in the report, is expected to record a 14.0% CAGR and reach US$44.7 Billion by the ... Read More
-
Lung Cancer Therapeutics
... at a CAGR of 10.8% over the analysis period 2024-2030. Non-Small-Cell Lung Cancer (NSCLC) Therapeutics, one of the segments analyzed in the report, is expected to record a 11.9% CAGR and reach US$82.3 Billion by ... Read More
-
Genitourinary Drugs
... CAGR of 2.3% over the analysis period 2024-2030. Urologicals, one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach US$10.7 Billion by the end of the analysis period. ... Read More
-
Rheumatoid Arthritis Therapeutics
... at a CAGR of 4.1% over the analysis period 2024-2030. Pharmaceuticals, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$28.0 Billion by the end of the ... Read More
-
Acne Drugs
... CAGR of 6.9% over the analysis period 2024-2030. Inflammatory Drugs, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$9.6 Billion by the end of the analysis ... Read More
-
Cannabis in South Africa
... of cannabis in private spaces. In turn, the change in the legislative environment significantly increased social acceptance, which drove consumption and cultivation rates across the country. Euromonitor International's Cannabis in South Africa market report offers ... Read More
-
Cannabis in the US
... I to Schedule III, which could attract more investment and improve banking access for cannabis businesses. Euromonitor International's Cannabis in USA market report offers a comprehensive guide to the size and shape of this emerging ... Read More
-
Medical Cannabis in Australia - Industry Market Research Report
... report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players ... Read More
-
International Directory of Medical Cannabis Companies 2025
International Directory of Medical Cannabis Companies 2025 The most comprehensive and accurate Directory of companies and executives in the medical cannabis industry Internationally. Extensive profiles of companies and each company's senior officials. Read More
-
Global Foot and Mouth Disease (FMD) Vaccines Competitive Landscape Professional Research Report 2025
... goats. The FMD virus can lead to significant economic losses in the livestock industry due to decreased milk production, reduced meat quality, and trade restrictions imposed on affected regions. FMD vaccines are crucial tools in ... Read More
-
Canada CBD-Infused Beverages Market - 2024-2031
... period 2024-2031. Consumers of the country are increasingly seeking wellness-oriented, non-intoxicating alternatives to traditional beverages, and CBD-infused drinks fit this demand. These products are marketed for their potential health benefits, such as stress relief, anxiety ... Read More
-
Global CBD-Infused Beverages Market - 2024-2031
... period 2024-2031. The global CBD-infused beverages market is driven by the rising demand for wellness products, with 4% of the population experiencing anxiety disorders and 74% feeling overwhelmed by stress, according to the Mental Health ... Read More
-
Cannabis in Italy
... Italian doctors, who were major prescribers of medical cannabis, retired and there was no generational turnover. This included eight doctors who had been prescribing since 2013 and were a point of reference for many patients. ... Read More
-
Global Pharmaceutical R&D Outsourcing Market - Focused Insights 2024-2029
... expanded its oncology portfolio by acquiring preclinical assets from Nerio Therapeutics to develop innovative checkpoint inhibitors for cancer, in a deal worth up to USD 1.3 billion. The company also partnered with Ochre Bio to ... Read More
-
Cannabis in Thailand
... in decline, a substantial number of cannabis shops opened in downtown provinces, leading to oversupply issues in Thailand. Over the course of the year and throughout the forecast period, the market is anticipated to continue ... Read More
-
Cannabis in Israel
... of just over 14%. However, in Q2 2024, economic growth had fallen to just 1.2% showing that the economy is under some pressure due to the ongoing negative effects on the economy of the Israel/Hamas ... Read More
-
Cannabis Cultivation Global Market Report 2025
... Growers Ltd.; Canntrust Holdings Inc; The Hydropothecary Corporation; Better Holdings Inc. Cannabis Cultivation Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to ... Read More
-
Cannabidiol Global Market Report 2025
... Application: Medical; Personal Use; Pharmaceuticals; Wellness 5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online StoresCovering: Endoca BV; Cannoid LLC; Medical Marijuana Inc.; Folium Biosciences; Elixinol Global Limited Cannabidiol Global Market Report 2025 from The ... Read More
-
Medical Cannabis Market Report by Species (Indica, Sativa, Hybrid), Derivatives (Cannabidiol (CBD), Tetrahydrocannabinol (THC), and Others), Application (Cancer, Arthritis, Migraine, Epilepsy, and Others), End-Use (Pharmaceutical Industry, Research and Development Centres, and Others), Route of Administration (Oral Solutions and Capsules, Vaporizers, Topicals, and Others), and Region 2025-2033
... (Oral Solutions and Capsules, Vaporizers, Topicals, and Others), and Region 2025-2033 The global medical cannabis market size reached USD 37.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 68.6 Billion ... Read More
Research Assistance
